Preparation of Acyloins from β-Dicarbonyl Compounds
FULL PAPER
CeCl3·7 H2O (30 mg, 0.081 mmol) in iPrOH (0.5 mL) were con-
verted to yield 5a after Workup A as a colorless liquid (282 mg,
1.64 mmol, 99%). All data are in accordance with the literature.[17]
1.27 mmol, 78%). All data are in accordance with the literature.[12]
Ethyl 1-Hydroxy-2-oxo-1-cyclohexanecarboxylate (5h): According
to the General Procedure, 4h (1.089 g, 6.380 mmol) and
CeCl3·7 H2O (119 mg, 0.320 mmol) in iPrOH (2.0 mL) were con-
verted to yield 5h after Workup C (110Ϫ180 °C/2 mbar) as a color-
less liquid (696 mg, 3.74 mmol, 59%). All data are in accordance
with the literature.[17]
L-Menthyl 1-Hydroxy-2-oxo-1-cyclopentanecarboxylate (5b): Ac-
cording to the General Procedure, 4b (202 mg, 0.758 mmol) and
CeCl3·7 H2O (15 mg, 0.040 mmol) in iPrOH (0.5 mL) were con-
verted to yield 5b after Workup A as a colorless liquid (211 mg,
0.747 mmol, 99%). All data are in accordance with the literature.[19]
2-Acetyl-2-hydroxycyclohexanone (5i): According to the General
Procedure, 4i (1.051 g, 7.498 mmol) and CeCl3·7 H2O (140 mg,
0.376 mmol) in iPrOH (2.4 mL) were converted to yield 5i after
Workup C (60Ϫ160 °C/2 mbar) as a colorless liquid (592 mg,
3.79 mmol, 51%). All data are in accordance with the literature.[9d]
Methyl 1-Hydroxy-2-oxo-1-cycloheptanecarboxylate (5c): Accord-
ing to the General Procedure, 4c (274 mg, 1.61 mmol) and
CeCl3·7 H2O (30 mg, 0.081 mmol) in iPrOH (0.5 mL) were con-
verted to yield 5c after Workup A as a colorless liquid (287 mg,
1.54 mmol, 96%). All data are in accordance with the literature.[17]
Ethyl 2-Hydroxy-2-methyl-3-oxobutanoate (5j): According to the
General Procedure, 4j (235 mg, 1.62 mmol) and CeCl3·7 H2O
(30 mg, 0.081 mmol) in iPrOH (0.5 mL) were converted to yield 5j
after Workup B (PE/EA, 5:1, Rf ϭ 0.19) as a colorless liquid
(75 mg, 0.47 mmol, 29%). All data are in accordance with the liter-
ature.[15]
α-Acetyl-N-benzyl-α-hydroxy-γ-butyrolactam (5d): According to the
General Procedure, 4d (328 mg, 1.51 mmol) and CeCl3·7 H2O
(30 mg, 0.081 mmol) in iPrOH (0.5 mL) were converted to yield 5d
after Workup A as a colorless crystalline solid (255 mg, 1.09 mmol,
1
72%). M.p. 84.5 °C. H NMR (CDCl3, 500 MHz): δ ϭ 2.10 (ddd,
J ϭ 13.5, J ϭ 8.8, J ϭ 7.8 Hz, 1 H), 2.30 (s, 3 H), 2.44 (ddd, J ϭ
13.5, J ϭ 6.9, J ϭ 3.7 Hz, 1 H), 3.27Ϫ3.35 (m, 2 H), 4.44 (d, J ϭ
14.7 Hz, 1 H), 4.57 (d, J ϭ 14.7 Hz, 1 H), 5.07 (br. s, 1 H),
7.19Ϫ7.36 (m, 5 H) ppm. 13C{1H} NMR (CDCl3, 125 MHz): δ ϭ
25.47 (CH3), 31.27 (CH2), 43.87 (CH2), 47.77 (CH2), 84.03 (C),
128.29 (CH), 128.47 (CH), 129.23 (CH), 135.67 (CH), 172.21 (C),
Ethyl 2-Ethyl-2-hydroxy-3-oxobutanoate (5k): According to the
General Procedure, 4k (255 mg, 1.61 mmol) and CeCl3·7 H2O
(30 mg, 0.081 mmol) in iPrOH (0.5 mL) were converted to yield 5k
after Workup B (PE/EA, 10:1, Rf ϭ 0.13) as a colorless liquid
(89 mg, 0.51 mmol, 32%). All data are in accordance with the liter-
ature.[4b]
208.21 (C) ppm. IR (KBr): ν˜ ϭ 3260 (br, s), 1714 (s), 1676 (s) cmϪ1
.
MS (70 eV, EI): m/z (%) ϭ 233 (5) [Mϩ], 217 (67), 191 (17), 174
(90), 91 (100). C13H15NO3 (233.26): calcd. C 66.94, H 6.48, N 6.00;
found C 67.20, H 6.53, N 5.90.
Ethyl 2-Acetyl-2-hydroxyhexanoate (5l): According to the General
Procedure, 4l (302 mg, 1.62 mmol) and CeCl3·7 H2O (30 mg,
0.081 mmol) in iPrOH (0.5 mL) were converted to yield 5l after
Workup B (PE/EA, 10:1, Rf ϭ 0.14) as a colorless liquid (149 mg,
1
α-Acetyl-N-benzyl-α-hydroxy-δ-valerolactam (5e): According to the
General Procedure, 4e (358 mg, 1.55 mmol) and CeCl3·7 H2O
(29 mg, 0.078 mmol) in iPrOH (0.5 mL) were converted to yield 5e
after Workup A as a colorless crystalline solid (327 mg, 1.32 mmol,
0.737 mmol, 45%). H NMR (CDCl3, 300 MHz): δ ϭ 0.90 (t, J ϭ
7.1 Hz, 3 H), 1.30 (t, J ϭ 7.1 Hz, 3 H), 1.16Ϫ1.40 (m, 4 H),
1.85Ϫ1.96 (m, 1 H), 2.04Ϫ2.23 (m, 1 H), 2.29 (s, 3 H), 4.17 (s, 1 H),
4.21Ϫ4.36 (m, 2 H) ppm. 13C{1H} NMR (CDCl3, 75 MHz): δ ϭ
13.87 (CH3), 14.06 (CH3), 22.69 (CH2), 24.68 (CH3), 25.22 (CH2),
34.94 (CH2), 62.58 (CH2), 84.24 (C), 171.02 (C), 205.11 (C) ppm.
IR (neat): ν˜ ϭ 3493 (br, s), 2961 (s), 2933 (s), 1749 (s), 1719 (vs)
cmϪ1. MS (70 eV, EI): m/z (%) ϭ 202 (1) [Mϩ], 160 (100), 85 (64),
43 (27). C10H18O4 (202.24): calcd. C 59.39, H 8.97; found C 59.30,
H 8.99.
1
85%). M.p. 102 °C. H NMR (CDCl3, 300 MHz): δ ϭ 1.83Ϫ1.99
(m, 3 H), 2.17Ϫ2.28 (m, 1 H), 2.30 (s, 3 H), 3.21Ϫ3.35 (m, 2 H),
4.50 (d, J ϭ 14.7 Hz, 1 H), 4.59 (s, 1 H), 4.75 (d, J ϭ 14.7 Hz, 1 H),
7.26Ϫ7.38 (m, 5 H) ppm. 13C{1H} NMR (CDCl3, 75 MHz): δ ϭ
18.62 (CH2), 24.59 (CH3), 30.67 (CH2), 47.06 (CH2), 50.71 (CH2),
79.40 (C), 127.68 (CH), 127.96 (CH), 128.77 (CH), 136.19 (C),
169.13 (C), 208.12 (C) ppm. IR (KBr): ν˜ ϭ 3316 (br, s), 2940 (m),
2875 (m), 1716 (s), 1622 (vs) cmϪ1. MS (70 eV, EI): m/z (%) ϭ 247
(2) [Mϩ], 230 (17), 204 (99), 91 (100). C14H17NO3 (247.29): calcd.
C 68.00, H 6.93, N 5.66; found C 67.91, H 6.95, N 5.48.
Ethyl 2-Hydroxy-2-isopropyl-3-oxobutanoate (5m): According to
the General Procedure, 4m (274 mg, 1.59 mmol) and CeCl3·7 H2O
(30 mg, 0.081 mmol) in iPrOH (0.5 mL) were converted to yield
5m after Workup B (PE/EA, 10:1, Rf ϭ 0.16) as a colorless liquid
(40 mg, 0.21 mmol, 13%). In a first fraction (Rf ϭ 0.21) starting
material 4m (174 mg, 1.01 mmol, 63%) was recovered. 1H NMR
(CDCl3, 500 MHz): δ ϭ 0.80 (d, J ϭ 6.7 Hz, 3 H), 0.94 (d, J ϭ
6.7 Hz, 3 H), 1.31 (t, J ϭ 7.2 Hz, 3 H), 2.32 (s, 3 H), 2.72 (sept,
J ϭ 6.8 Hz, 1 H), 4.10 (s, 1 H), 4.22Ϫ4.33 (m, 2 H) ppm. 13C{1H}
NMR (CDCl3, 125 MHz): δ ϭ 14.09 (CH3), 15.97 (CH3), 16.80
(CH3), 25.18 (CH), 33.77 (CH3), 62.59 (CH2), 87.79 (C), 170.84
(C), 205.83 (C) ppm. IR (ATR): ν˜ ϭ 3482 (br, s), 2972 (s), 1721
(vs), 1261 (s), 1177 (s), 1155 (s) cmϪ1. MS (70 eV, EI): m/z (%) ϭ
189 (10) [MHϩ], 171 (13), 146 (34), 115 (72), 71 (100), 43 (90).
C9H16O4 (188.22): calcd. C 57.43, H 8.57; found C 57.63, H 8.52.
α-Acetyl-α-hydroxy-ε-caprolactone (5f): According to the General
Procedure, 4f (250 mg, 1.60 mmol) and CeCl3·7 H2O (30 mg,
0.081 mmol) in iPrOH (0.5 mL) were converted to yield 5f after
Workup A as a colorless crystalline solid (227 mg, 1.32 mmol,
83%). M.p. 70Ϫ72 °C. 1H NMR (CDCl3, 500 MHz): δ ϭ
1.74Ϫ1.88 (m, 3 H), 1.94Ϫ2.06 (m, 2 H), 2.09Ϫ2.17 (m, 1 H), 2.39
(s, 3 H), 4.27 (ddd, J ϭ 12.3, J ϭ 6.9, J ϭ 2.0 Hz, 1 H), 4.60 (s,
1 H), 4.79 (ddd, J ϭ 12.2, J ϭ 9.4, J ϭ 1.4 Hz, 1 H) ppm. 13C{1H}
NMR (CDCl3, 125 MHz): δ ϭ 22.81 (CH2), 24.98 (CH3), 29.07
(CH2), 32.28 (CH2), 69.94 (CH2), 82.35 (C), 172.43 (C), 204.94 (C)
ppm. IR (KBr): ν˜ ϭ 3443 (br, vs), 2974 (m), 2943 (s), 1703 (br, vs)
cmϪ1. MS (CH4, CI): m/z (%) ϭ 173 (21) [MHϩ], 155 (15), 130
(49), 127 (100). C8H12O4 (172.18): calcd. C 55.81, H 7.02; found C
55.81, H 6.98.
Ethyl 2-Hydroxy-2-methyl-3-oxo-3-phenylpropanoate (5n): Accord-
ing to the General Procedure, 4n (270 mg, 1.31 mmol) and
CeCl3·7 H2O (20 mg, 0.054 mmol) in iPrOH (0.5 mL) were con-
verted to yield 5n after Workup B (toluene/EA, 30:1, Rf ϭ 0.16) as
a colorless liquid (87 mg, 0.39 mmol, 30%). In a first fraction (Rf ϭ
0.29) starting material 4n (43 mg, 0.21 mmol, 16%) was recovered.
α-Acetyl-α-hydroxy-γ-butyrolactone (5g): According to the General
Procedure, 4g (208 mg, 1.62 mmol) and CeCl3·7 H2O (30 mg,
0.081 mmol) in iPrOH (0.5 mL) were converted to yield 5g after
Workup B (PE/EA, 1:1, Rf ϭ 0.26) as a yellow oil (183 mg, All data are in accordance with the literature.[19]
Eur. J. Org. Chem. 2003, 425Ϫ431
429